Selmi Macchia Weight

Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

[1] Thomas DL, Lemon SM, Hepatitis C. In: Mandell Gl, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th edition. Philadelphia: Churchill Livingstone; 2005. p. 1950-81.

[2] Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR 2006;55(No. RR-11):1-94.

[3] Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 2006;8(1):53-9.

[4] Giordano N, Amendola A, Papakostas P, et al. Immune and autoimmune disorders in HCV chronic liver disease: personal experience and commentary on literature. New Microbiol 2005;28(4):311-7.

[5] Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. The MULTIVIRC group. Multidepartment virus C. Arthritis Rheum 1999;42(10): 2204-12.

[6] Zignego AL, Macchia D, Monti M, et al. Infection of peripheral mononuclear cells by hepatitis C virus. J Hepatol 1992;15:382-6.

[7] Cacoub P, Renou C, Rosental E, et al. Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of321 patients. Medicine (Baltimore) 2000; 79(1):47-56.

[8] Starkebaum G, Sasso EH. Hepatitis C and B cells: induction of autoimmunity and lympho-proliferation may reflect chronic stimulation through cell-surface receptors. J Rheumatol 2004;31(3):416-8.

[9] Ali A, Zein NN. Hepatitis C infection: a systemic disease with extrahepatic manifestations. Cleve Clin J Med 2005;72(11):1005-8, 1010-4, 1016, 1019.

[10] Vassilopoulos D, Calabrese LH. Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002;46(3):585-97.

[11] Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 2005;5(4):227-36.

[12] Pachas WN, Pinals RS. A rheumatic syndrome with Laennec's cirrhosis. Arthritis Rheum 1967;10(4):343-7.

[13] Olivieri I, Palazzi C, Padula A. Hepatitis C virus and arthritis. Rheum Dis Clin North Am 2003;29(1):111-22.

[14] Rosner I, Rozenbaum M, Toubi E, et al. The case for hepatitis C arthritis. Semin Arthritis Rheum 2004;33(6):375-87.

[15] Maillefert JF, Muller G, Falgarone G. Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. Ann Rheum Dis 2002;61(7):635-7.

[16] Zerrak A, Bour JB, Tavernier C, et al. Usefulness of routine hepatitis C virus, hepatitis B virus, and parvovirus B19 serology in the diagnosis of recent-onset inflammatory arthritides. Arthritis Rheum 2005;53(3):477-8.

[17] Saraux A, Fautrel B, Maillefert JF, et al. Laboratory and imaging studies by French rheumatologists to evaluate patients with early arthritis. J Rheumatol 2006;33(5): 897-902.

[18] Barbosa VS, da Silva NA, Marins RM. Hepatitis C virus seroprevalence and genotypes in patients with diffuse connective tissue diseases and spondyloarthropathies. Braz J Med Biol Res 2005;38(5):801-5.

[19] Martins RM, Vanderborght BO, Rouzere CD, et al. Anti-HCV related to HCV PCR and risk factors analysis in a blood donor population of central Brazil. Rev Inst Med Trop Sao Paulo 1994;36(6):501-6.

[20] Ramos-Casals M, Jara LJ, Medina F, et al. Systemic autoimmune diseases coexisting with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 2005;257(6):549-57.

[21] Niewold TB, Gibofsky A. Concomitant interferon-a therapy and tumor necrosis factor a inhibition for rheumatoid arthritis and hepatitis C. Arthritis Rheum 2006;54(7):2335-7.

[22] Akhtar AJ, Funnye AS. Hepatitis C virus associated arthritis in absence of clinical, biochemical and histological evidence of liver disease-responding to interferon therapy. Med Sci Monit 2005;11(7):CS37-9.

[23] Zuckerman E, Keren D, Rozenbaum M, et al. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha. Clin Exp Rheumatol 2000;18(5): 579-84.

[24] Nissen MJ, Fontanges E, Allam Y, et al. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methrotrexate and interferon. Rheumatol 2005;44:1016-20.

[25] Trejo O, Ramos-Casals M, Garcia-Carrasco M, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine 2001;80(4):252-62.

[26] Trendelenburg M, Schifferli JA. Cryoglobulins in chronic hepatitis C virus infection. Clin Exp Immunol 2003;133(2):153-5.

[27] Morra E. Cryoglobulinemia. Hematology Am Soc Hematol Educ Program 2005:368-72.

[28] Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3): 315-24.

[29] van Boekel M, Vossenaar ER, van den Hoogen FH, et al. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002;4(2):87-93.

[30] Bombardieri M, Alessandri C, Labbadia G, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004;6(2): R137-41.

[31] Girelli F, Foschi FG, Bedeschi E, et al. Is anti cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Allerg Immunol (Paris) 2004;36(4): 127-30.

[32] Cojocaru M, CojocaruIM, Iacob SA. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection. Rom J Intern Med 2004;42(4):709-14.

[33] Ueno Y, Kinoshita R, Kishimoto I, et al. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994;33(3):289-91.

[34] Cimmino MA, Picciotto A, Sinelli N, et al. Has hepatitis C virus a specific tropism for the synovial membrane? Br J Rheumatol 1997;36(4):505-6.

[35] D'Amico E, Palazzi C, Cacciatore P, et al. Anti-ENA antibodies in patients with chronic hepatitis C virus infection. Dig Dis Sci 2002;47(4):755-9.

[36] Wu YY, Hsu TC, Chen TY, et al. Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 2002; 128(2):347-52.

[37] Dalekos GN, Kristis KG, Boumba DS, et al. Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 2000;12(1):67-74.

[38] Lienesch DW, Sherman KE, Metzger A, et al. Anti-Clq antibodies in patients with chronic hepatitis C infection. Clin Exp Rheumatol 2006;24(2):183-5.

[39] Bogdanos DP, Rigipoulou EI. Self-mimicking autoimmune domains of hepatitis C virus core antigen. Vaccine 2006;24:6173-4.

[40] Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117(7):573-7.

[41] Mariette X. Hepatitis C virus, arthritides, and arthromyalgia. Joint Bone Spine 2003;70(4): 246-7.

[42] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic hep-atitisC: current disease management. Available at: http://digestive.niddk.nih.gov/ddiseases/ pubs/chronichepc/index.htm. Accessed August 25, 2006.

[43] Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 2000;43:1431-42.

[44] Selmi C, Lleo A, Zuin M, et al. Interferon alpha and its contribution to autoimmunity. Curr Opin Investig Drugs 2006;7(5):451-6.

[45] Wilson LE, Widman D, Dikman SH, et al. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 2002;32(3):163-73.

[46] Murata K, Shiraki K, Takase K, et al. Mono-arthritis following intensified interferon beta therapy for chronic hepatitis C. Hepatogastroenterology 2002;49(47):1418-9.

[47] Sood A, Midha V, Sood N. Rheumatoid arthritis probably induced by pegylated interferon in a patient with chronic hepatitis C. Indian J Gastroenterol 2004;23(1):28-9.

[48] Cacoub P, Saadoun D, Limal N, et al. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2005;52(3): 911-5.

[49] Mazzaro C, Zorat F, Caizzi M, et al. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatology 2005;42(5): 632-8.

[50] Teoh NC, Farrell GC. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clin Liver Dis 2003;7(2):401-13.

[51] De Ledinghen V, Heresbach D, Fourdan O, et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut 1999;44(2):270-3.

[52] Rostom A, Goldkind L, Laine L. Nonsteroidal anti-inflammatory drugs and hepatic toxic-ity: a systematic review of randomized controlled trials in arthritis patients. Clin Gastroen-terol Hepatol 2005;3(5):489-98.

[53] Riley TR, Smith JP. Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series. Am J Gastroenterol 1998;93(9):1563-5.

[54] Andrade RJ, Lucena MI, Garcia-Cortes M, et al. Chronic hepatitis C, ibuprofen, and liver damage. Am J Gastroenterol 2002;97(7):1854-5.

[55] Brok J, Mellerup MT, Krogsgaard K, et al. Glucocorticosteroids for viral hepatitis C. Cochrane Database Syst Rev 2004;2:CD002904. Available at:. http://www.cochrane.org/ reviews/en/ab002904.html. Accessed August 29, 2006.

[56] Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996;23(6):979-83.

[57] Mok MY, Ng WL, Yuen MF, et al. Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol 2000;18(3): 363-8.

[58] Khanna M, Shirodkar MA, Gottlieb AB. Etanercept therapy in patients with autoimmunity and hepatitis C. J Dermatol Treatment 2003;14:229-32.

[59] Peterson JR, Hsu FC, Simkin PA, et al. Effect of tumor necrosis factor a antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis 2003;62:1078-82.

[60] Parke FA, Reveille JD. Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection. Arthritis Rheum 2004;51(5):800-4.

[61] Marotte H, Fontanges E, Bailly F, et al. Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus. Rheumatology (Oxford) 2006 (doi:10.1093/rheumatology/kel191). Available at: http://rheumatology. oxfordjournals.org/cgi/reprintkel191v1. Accessed October 16, 2006. [Epub ahead of print.]

[62] Magliocco MA, Gottlieb AB. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of3 cases. J Am Acad Dermatol 2004;51:580-4.

[63] Rokhsar C, Rabhan N, Cohen SR. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection. J Am Acad Dermatol 2006; 54(2):361-2.

[64] Roux CH, Brocq O, Breuil V, et al. Safety of anti-TNF-a therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis. Rheumatology (Oxford) 2006;45:1294-7.

[65] Pritchard C. Etanercept and hepatitis C. J Clin Rheumatol 1999;5:179-80.

[66] Kremer JM, Alarcon GS, Lightfoot RW Jr, et al. Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994;37(3):316-28.

[67] Kujawska A, Clements M, Wise CM, et al. Hepatitis C and methotrexate. Arthritis Rheum 2003;49(6):843-5.

[68] Palazzi C, Olivieri I, Cacciatore P, et al. Management of hepatitis C virus-related artritis. Expert Opi Pharmacother 2005;6(1):27-34.

[69] Kayali Z, Buckwold VE, Zimmerman B, et al. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002;36(4 Pt 1):978-85.

Was this article helpful?

0 0
Natural Arthritis Pain Remedies

Natural Arthritis Pain Remedies

It's time for a change. Finally A Way to Get Pain Relief for Your Arthritis Without Possibly Risking Your Health in the Process. You may not be aware of this, but taking prescription drugs to get relief for your Arthritis Pain is not the only solution. There are alternative pain relief treatments available.

Get My Free Ebook


Post a comment